1 min read.Updated: 17 Jun 2021, 04:25 PM ISTLivemint
The clinical trials of Covavax are in an advanced stage of completion in India
Serum Institute of India (SII), the maker of Covishield vaccine, is expecting to launch another vaccine, Covavax, in the country by September, news agency ANI reported, citing sources. Covavax is a version of US firm Novavax's COVID19 vaccine candidate. The clinical trials of Covavax are in an advanced stage of completion in India.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.